August 27, 2024
Cigna’s Express Scripts to Remove Humira from Preferred Lists in Favor of Cheaper Biosimilars
Cigna, Express Scripts, Humira, biosimilars, drug pricing, pharmaceutical industry
Roche’s PiaSky Receives European Approval for Rare Blood Disorder Treatment
Roche, PiaSky, Crovalimab, Paroxysmal Nocturnal Hemoglobinuria (PNH), Rare Blood Disorder, European Approval
MBX Biosciences Enters IPO Queue Amid End-of-Summer Rush
MBX Biosciences, IPO, NASDAQ, peptide therapeutics, biotech, public offering
Merck’s WINREVAIR Receives EU Approval for Pulmonary Arterial Hypertension Treatment
WINREVAIR, Merck, EU Approval, Pulmonary Arterial Hypertension, PAH Treatment
Regeneron Secures EU Approval for Lymphoma Treatment Ordspono Following FDA Rejection
Regeneron, EU approval, lymphoma, bispecific antibody, odronextamab, Ordspono, FDA rejection
Qventus Launches AI Operational Assistants to Boost Healthcare Productivity
Qventus, AI Operational Assistants, Healthcare Productivity, Administrative Tasks, Patient Care
UCB Divests Mature Neurology and Allergy Portfolio in China for $680M
UCB, China, neurology, allergy, divestment, CBC Group, Mubadala, pharmaceuticals, innovation, strategic partnerships